Adjuvance Technologies, Inc
Lincoln, United States (US) · Health and Medical
Do your work at Adjuvance Technologies, Inc?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Adjuvance Technologies, Inc is a Health and Medical company based in Lincoln, United States (US), with 10-20 employees. Adjuvance Technologies, Inc's profile is verified on Enterprise League.
Overview
Adjuvance Technologies is a Lincoln, Nebraska-based biopharmaceutical company specializing in the design and manufacturing of innovative vaccine adjuvants. We focus on empowering global health by driving fundamental breakthroughs in immunology. Our core expertise lies in therapeutic vaccines and adjuvant immunopotentiation, offering solutions to pharmaceutical and biotechnology companies seeking to enhance vaccine efficacy. We collaborate closely with organizations like Memorial Sloan-Kettering Cancer Center to translate our research into impactful therapies.
Adjuvance Technologies develops and produces advanced adjuvant formulations, crucial for stimulating robust immune responses to vaccines. Our work supports the development of next-generation vaccines targeting a wide range of diseases, including cancer and infectious diseases. We are dedicated to accelerating vaccine development and improving patient outcomes.
Founded on a foundation of scientific excellence and entrepreneurial spirit, Adjuvance Technologies combines deep immunological knowledge with a commitment to commercialization. With a team of experienced professionals, we are uniquely positioned to deliver cutting-edge adjuvant technologies to the global market. We are a privately held company with a dedicated team of 11-50 employees.
Adjuvance Technologies develops and produces advanced adjuvant formulations, crucial for stimulating robust immune responses to vaccines. Our work supports the development of next-generation vaccines targeting a wide range of diseases, including cancer and infectious diseases. We are dedicated to accelerating vaccine development and improving patient outcomes.
Founded on a foundation of scientific excellence and entrepreneurial spirit, Adjuvance Technologies combines deep immunological knowledge with a commitment to commercialization. With a team of experienced professionals, we are uniquely positioned to deliver cutting-edge adjuvant technologies to the global market. We are a privately held company with a dedicated team of 11-50 employees.
Contact Details
info@adjuvancetechnologies.org
Lincoln, United States (US), 1225 L St
Company Type
Private Limited Company
Employees
10-20
Categories
Companies teams usually look at after Adjuvance Technologies, Inc
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.